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Abstract 
Although solution additives prevent protein misfolding, the mechanism remains elusive.  
In this paper, we compare the preventive effects of trans-1,2-cyclohexanediamine and 
trans-1,4-cyclohexanediamine on the heat-induced inactivation of ribonuclease A and 
lysozyme.  These additives are more effective in preventing thermal inactivation of the 
proteins than guanidine and arginine.  The results suggest two possibilities: (i) 
decrease in the hydrophobic interaction between unfolded protein molecules is 
indispensable for preventing protein association, and (ii) the electrostatic interaction 
between additives interacting with the hydrophobic residues of protein molecules plays 
an important role in preventing thermal inactivation of proteins.   
Keywords 
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interaction 
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1. INTRODUCTION 
Protein aggregation is a serious problem for biotechnology and pharmaceutical 
applications (Fink, 1998; Kopito, 2000; Tsumoto et al., 2003).  Many studies have 
shown that the aggregation proceeds as a first-order reversible folding/unfolding 
reaction and subsequent intermolecular association with a higher-order irreversible 
process (Georgiou et al., 1994; Winzor et al., 1992).  The aggregation is generally 
affected by the solution conditions, such as temperature, pH, concentration of protein, 
and the presence of additives.  The additives affect the stability of the native structure 
and the aggregation rate of proteins (Tsumoto et al., 2004; Shiraki et al., 2004, Hirano et 
al., 2007).  Guanidine (Gdn) and urea are well-used additives as aggregation 
suppressors that weaken hydrophobic intermolecular interaction of proteins (Dunbar et 
al., 1997; Bhuyan, 2002).  These denaturant molecules increase the solubility of 
aggregation-prone unfolded molecules, but decrease the stability of the native state.  
Arginine (Arg) has been used in various techniques, such as chromatography (Ejima et 
al., 2005a, b), refolding (Tsumoto et al., 1998; Umetsu et al., 2003; Ishibashi et al., 
2005; Chow et al., 2006; Ejima et al., 2006), and thermal aggregation suppression 
(Shiraki et al., 2002), because it does not destabilize the native state but increases the 
solubility of aggregation-prone molecules (Tsumoto et al., 2004;Arakawa and Tsumoto, 
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2003; Shiraki et al., 2002; Shiarki et al., 2004). 
Many chemicals containing an amino group effectively prevent heat-induced 
aggregation and inactivation of lysozyme, such as polyamines (Kudou et al., 2003), 
diamines (Okanojo et al., 2005), amino acid derivatives (Shiraki et al., 2005; Hamada 
and Shiraki, 2007; Matsuoka et al., 2007), and ammonium ion (Hirano et al., 2007).  
Although these additives have been developed to control protein aggregation in the field 
of biotechnology, only a few molecular mechanisms have been elucidated, such as (i) 
monoamine and diol did not prevent thermal inactivation and aggregation of lysozyme 
(Okanojo et al., 2005); (ii) amine compounds show weak denaturing properties of 
proteins (Okanojo et al., 2005); (iii) ammonium ions increase the solubility of 
hydrophobic amino acids (Hirano et al., 2007). 
Recent research on additives suggests that the solubility of hydrophobic amino 
acids is an important factor in assessing the effect of additives, because it indicates the 
strength of the interaction with hydrophobic residues of protein (Tsumoto et al., 2004; 
Hirano et al., 2007).  Briefly, the additives that dissolve hydrophobic amino acids may 
be better at preventing thermal inactivation and aggregation due to weakened 
hydrophobic interaction between protein molecules.   
In this paper, we show that trans-cyclohexanediamines (CHDAs) prevent thermal 
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inactivation of ribonuclease A and lysozyme and we propose two mechanisms for 
prevention of heat-induced inactivation of proteins.   
 
2. MATERIALS AND METHODS 
2.1. Materials 
Hen egg white lysozyme, bovine ribonuclease A (RNase A), cytidine 2′:3′-cyclic 
monophosphate sodium salt (cCMP), Arg, Gdn, and 3-(N-morpholino)propanesulfonic 
acid were obtained from Sigma Chemical Co. (St. Louis, USA).  NaH2PO4 was 
obtained from Nacalai Tesque, Inc (Kyoto, Japan).  trans-1,2-cyclohexanediamine 
(1,2-CHDA) and trans-1,4-cyclohexanediamine (1,4-CHDA) were obtained from Tokyo 
Kasei Kogyo Co., Ltd. (Tokyo, Japan).  HCl, NaOH, and Micrococcus lysodeikticus 
were obtained from Wako Pure Chemical Indus., Ltd. (Osaka, Japan).  All chemicals 
used were of high-quality analytical grade. 
 
2.2 Residual activity of lysozyme after heat treatment 
The bacteriolytic activity of lysozyme was estimated as follows.  A total of 1.5 ml of 
0.5 mg/ml Micrococcus lysodeikticus solution prepared in 50 mM sodium-phosphate 
buffer was adjusted to pH 7.0 by HCl or NaOH and was mixed with 10 μl of the protein 
Hirano et al. 7 
solution.  The decrease in light scattering intensity of the solution was monitored by 
measuring the absorbance at 600 nm.  The residual activity was estimated from the 
slope of the initial decrease in the intensity. 
 
2.3. Residual activity of RNase A after heat treatment 
The activity of RNase A was estimated as follows.  A total of 1.5 ml of 0.1 mg/ml 
cCMP solution prepared in 0.1 M 3-(N-morpholino)propanesulfonic acid buffer was 
adjusted to pH 7.0 by HCl or NaOH and was mixed with 10 μl of the protein solution.  
The increase in the light scattering intensity of the solution was monitored by measuring 
the absorbance at 284 nm.  The residual activity was estimated from the slope of the 
initial increase in the intensity. 
 
2.4. Thermal inactivation in the presence of CHDAs 
Heat-induced inactivation of RNase A and lysozyme were performed as follows.  A 
stock solution containing 2.0 mg/ml RNase A or 0.5 mg/ml lysozyme, 50 mM 
Na-phosphate buffer, and 0-0.1 M CHDAs, Arg, or Gdn was prepared and adjusted to 
pHs 7.0 or 8.3 by HCl or NaOH.  A total of 200 μl of the stock solutions were added to 
micro disposal tubes.  The solutions were heated at 98°C for measured periods (10 min 
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or 3 min) using a temperature control system PC-880 (Astec, Fukuoka, Japan).  After 
the heat treatment, the samples were centrifuged at 15,000 g for 20 min at 20°C, and 
then the amounts of residual activity of soluble protein were measured.   
 
2.5. Time course of thermal inactivation 
Heat-induced inactivation of RNase A and lysozyme was performed as follows.  A 
stock solution containing 2.0 mg/ml RNase A or 0.5 mg/ml lysozyme, 50 mM 
Na-phosphate buffer, and 0.1 M CHDAs was prepared.  A total of 200 μl of the stock 
solutions was added to micro disposal tubes.  The solutions were heated at 98°C for 
various periods using a temperature control system PC-880.  After the heat treatment, 
the samples were centrifuged at 15,000 g for 20 min at 20°C, and then the amounts of 
residual activity of soluble protein were measured.  The obtained data were fitted to 
single exponential equations and the rate constants of inactivation were estimated.  The 
all measurements were performed three times and the standard errors were plotted.   
 
2.6. Solubility of amino acids in CHDA solutions 
Solution containing 1.0 M CHDAs and excess concentrations of phenylalanine (Phe) or 
isoleucine (Ile) were adjusted to various pHs by HCl or NaOH and were incubated with 
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shaking at 37 °C for 1 hour.  After that, the samples were incubated at 25°C for 10 
hour.  After the treatment, the samples were filtrated by 0.20 μm disposable syringe 
filter from Toyo Roshi Kaisha, Ltd. (Tokyo, Japan).  The soluble concentrations of 
amino acids were determined by high performance liquid chromatography (HPLC).  
HPLC equipment consisted of BioLogic DuoFlow system (Bio-Rad Laboratories, Inc., 
Tokyo, Japan) and a reverse phase C30 column, Develosil RPAQUEOUS-AR-5 
(Nomura Chemical Co, Ltd., Aichi, Japan).  The solutions containing saturated amino 
acid and 0.1 M CHDAs were diluted 25-fold for Phe solution or 10-fold for Ile solutions 
with pure water and then the samples of 20 μl were injected in the HPLC.  The mobile 
phases for analysis of Phe and Ile were pure water and 5% acetonitrile with 0.1% TFA 
in pure water, respectively.  The flow-rate was 1.0 ml/min at room temperature.  The 
solubility was determined by the peak areas and was calculated by the calibration curves.  
The all measurements were performed three times and the standard errors were plotted.  
The detection wavelengths of Phe and Ile were 220 and 205 nm, respectively.   
 
3. RESULTS AND DISCUSSION 
3.1 Thermal inactivation of RNase A and lysozyme in the presence of CHDAs 
Figure 1A and B show the amounts of residual activity of 2.0 mg/ml RNase A in the 
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presence CHDAs, Arg, or Gdn after heat treatment at 98°C for 10 min (pH 7.0) and 3 
min (pH 8.3).  The residual activity of RNase A increased with increasing 
concentration of CHDAs.  At pH 7.0, the preventive effect of 1,2-CHDA on the heat 
inactivation was higher than that of 1,4-CHDA at pH 7.0 (Fig. 1A), while at pH 8.3, the 
preventive effect of 1,4-CHDA was higher than that of 1,2-CHDA (Fig. 1B).  Figure 
1C and D show residual activity of 0.5 mg/ml lysozyme in the presence of CHDAs, Arg, 
or Gdn after the heat treatment at 98°C for 10 min (pH 7.0) and 3 min (pH 8.3).  The 
data for lysozyme were similar to those for RNase A; the residual activity of lysozyme 
increased with increasing concentration of CHDAs.  CHDAs had a more favorable 
effect than Arg and Gdn for preventing the thermal inactivation of the proteins.  
Figure 2 shows time course of the thermal inactivation of 2.0 mg/ml RNase A and 
0.5 mg/ml lysozyme in the presence of 0.1 M CHDAs at pH 7.0 and 8.3.  At pH 7.0, 
the thermal inactivation rates of RNase A and lysozyme in the presence of 1,2-CHDA 
were slower than in the presence of 1,4-CHDA (Fig. 2A and C).  However, at pH 8.3, 
the inactivation rates of each protein in the presence of 1,4-CHDA were slower than that 
in the presence of 1,2-CHDA (Fig. 2B and D).  These data indicate that the ability of 
CHDAs to prevent the thermal inactivation of the proteins depends on the pHs; 
1,2-CHDA was favorable at pH 7.0, while 1,4-CHDA was favorable at pH 8.3. 
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Figure 3 shows the relationships between inactivation rate constants and the pH for 
RNase A and lysozyme.  The rate constants of the inactivation for each protein in the 
presence of 1,2-CHDA were lower than in the presence of 1,4-CHDA below pH 7.8.  
However, above pH 7.8, the rate constants in the presence of 1,4-CHDA were lower 
than those of 1,2-CHDA.  The rate constants of the inactivation in each CHDA 
solution were equal at around pH 7.8.   
 
3.2. Solubility of hydrophobic amino acids in the presence of CHDAs 
Additives that prevent protein inactivation and aggregation increase the solubility of 
hydrophobic amino acids (Hirano et al., 2007).  In order to clarify the effect of CHDAs 
in preventing the inactivation, we investigated the solubility of hydrophobic amino 
acids (Phe and Ile) in the presence of 1,2-CHDA and 1,4-CHDA at various pHs (Fig. 4).  
At neutral pHs, Phe and Ile in 1 M 1,2-CHDA solution were dissolved more than in 
1,4-CHDA.  At alkaline pHs, however, 1,2-CHDAs dissolved the hydrophobic amino 
acids as much as 1,4-CHDA.  
 
3.3. Effects of CHDAs for preventing thermal inactivation of proteins 
The data for the thermal inactivation of the proteins with CHDAs are summarized as 
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follows: (i) below pH 7.8, 1,2-CHDA prevented the thermal inactivation of the proteins 
more effectively than 1,4-CHDA; (ii) above pH 7.8, 1,4-CHDA prevented the thermal 
inactivation of the proteins more effectively than 1,2-CHDA; (iii) below pH 8.5, 
1,2-CHDA showed higher solubility of hydrophobic amino acids than 1,4-CHDA; (iv) 
above pH 8.5, 1,2-CHDA and 1,4-CHDA showed similar solubility of the hydrophobic 
amino acids.   
Consideration of the solubility of amino acids partially accounts for the thermal 
inactivation of the proteins in the presence of CHDAs.  Since 1,2-CHDA dissolve 
more hydrophobic amino acids than 1,4-CHDA below pH 7.8, 1,2-CHDA molecules 
may interact with the hydrophobic surface of thermal unfolded protein molecules more 
favorably than 1,4-CHDA, leading to increased solubility of aggregation-prone 
misfolded molecules and more effective prevention of thermal inactivation than 
1,4CHDA below pH 7.8.  On the other hand, 1,4-CHDA more effectively prevented 
the protein inactivation than 1,2-CHDA in the alkaline pH region (>7.8) (Fig. 3), 
although 1,2-CHDA dissolved hydrophobic amino acids not less than 1,4-CHDA in the 
pH region (Fig. 4).  Therefore, not all of the solubility of the hydrophobic amino acids 
in CHDA solutions explains the prevention of the thermal inactivation of the proteins. 
As CHDAs have two possible protonation sites, it is important to know the charged 
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states of CHDAs to understand the ability of the additives to prevent the thermal 
inactivation of proteins.  Figure 5 shows pH titration profiles of 1,2-CHDA and 
1,4-CHDA.  The pKa of 1,2-CHDA were at around 6.5 and 10, while those of 
1,4-CHDA were at around 10.  In acidic pH (<4.5), a net charge of 1,2-CHDA was 
about 2.0, which was similar to that of 1,4-CHDA, whereas in pH 5-11 (especially, pH 
7.8-8.5), a net charge of 1,4-CHDA was larger than that of 1,2-CHDA.  At pH 7.8, the 
net charge of 1,4-CHDA was about 2.0, while that of 1,2-CHDA was about 1.0.  At pH 
8.5, the charge of 1,4-CHDA was about 1.9, while that of 1,2-CHDA was about 1.0.   
This fact supports the hypothesis that 1,4-CHDA would electrostatically prevent 
protein inactivation above pH 7.8 even if 1,4-CHDA interacts with hydrophobic 
residues of the protein less than 1,2-CHDA in the pH region (Fig. 4).   
In this work, new additives CHDAs that prevent thermal inactivation were found 
and two mechanisms were proposed; these data suggest that the prevention of the 
thermal inactivation depends on not only the hydrophobic interaction between 
hydrophobic surfaces of protein molecules but also the electrostatic interaction between 
CHDA molecules interacting with protein molecules.  These findings are useful for 
biotechnology and pharmaceutical industries.   
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FIGURE CAPTIONS 
Fig. 1. Heat-induced inactivation on RNase A and lysozyme in the presence of 
CHDAs.  Samples containing 2.0 mg/ml RNase A (A,B) and 0.5 mg/ml lysozyme 
(C,D) in the presence of CHDAs, Arg, or Gdn at pH 7.0 (A,C) and pH 8.3 (B,D) were 
heated at 98°C for 10 min (A,C) or 3min (B,D).  1,2-CHDA, closed circles; 1,4-CHDA, 
open circles; Arg, closed squares; Gdn, open squares. 
 
Fig. 2. Representative data for heat-induced inactivation of RNase A and lysozyme in 
the presence of additives.  Samples containing 2.0 mg/ml RNase A (A,B) or 0.5 mg/ml 
lysozyme (C,D), 50 mM Na-phosphate, and 100 mM additives were heated at 98°C for 
the respective periods at pH 7.0 (A,C) and at pH 8.3 (B,C).  After the heat treatment, 
the residual activity was determined.  1,2-CHDA, closed circles; 1,4-CHDA, open 
circles.  The continuous lines show the theoretical curves fitted to the data with single 
exponential equations.  
 
Fig. 3. Rate constants of heat-induced inactivation of RNase A (A) and lysozyme (B) 
at various pHs.  1,2-CHDA, closed circles; 1,4-CHDA, open circles.   
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Fig. 4. The solubility of Phe (A) and Ile (B) in the presence of 1.0 M CHDAs at 
various pHs.  1,2-CHDA, closed circles; 1,4-CHDA, open circles.   
 
Fig. 5. Estimation of net charge of 1,2-CHDA and 1,4-CHDA at various pHs by the 
titration.  A small quantity of 1.0 M HCl was added to 5 mL of 50 mM 1,2-CHDA 
(closed circles) or 1,4-CHDA (open circles) solution. 
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